Tender Details

Country: Poland
Summary: Conducting Tests in 2025 and 2026 (12 Months from the Date of Awarding the Contract) to Assess the Quality of Immunological and Biologically Active Medicinal Products.
PLT Ref No: 130544280
Deadline: 27 Nov 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 2025/BZP 00541411/01
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
SECTION II BASIC INFORMATION
2.1.) The announcement concerns:
Framework Agreement
2.2.) The announcement concerns social services and other specific services: No
2.3.) Name of the order or framework agreement:
Carrying out quality assessment studies in 2025 and 2026 (12 months from the date of award of the contract) immunological and biologically active medicinal products.
2.4.) Procedure ID: ocds-148610-2f473334-3f10-4287-9c3e-1eb9a3dfd7e3
2.5.) Announcement number: 2025/BZP 00541411
2.6.) Announcement version: 01
2.7.) Date of announcement: 2025-11-19
2.8.) Order or framework agreement were included in the action plan: Yes
2.9.) BZP proceedings plan number: 2025/BZP 00154310/03/P
2.10.) Procedure plan item identifier:
1.3.6 Planned trials of immunological and biologically active medicinal products in 2026
2.11.) They may apply for the award of a contract only contractors referred to in Art. 94 of the Act: No
2.14.) Does the order or framework agreement concern a project or program co-financed by the European Union: No
2.17.) Procedure for concluding a framework agreement along with the legal basis
The framework agreement is awarded in the basic mode based on: art. 311 section 1 point 2 of the Act in connection with joke. 275 point 1 of the Act
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conducting Tests in 2025 and 2026 (12 Months from the Date of Awarding the Contract) to Assess the Quality of Immunological and Biologically Active Medicinal Products. - Poland Tender

The CHIEF PHARMACEUTICAL INSPECTORATE, a Government sector organization in Poland, has announced a new tender for Conducting Tests in 2025 and 2026 (12 Months from the Date of Awarding the Contract) to Assess the Quality of Immunological and Biologically Active Medicinal Products.. This tender is published on PolandTenders under PLT Ref No: 130544280 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-27.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.